Indoco Remedies acquires CRO division of Piramal Enterprises

02 Apr 2015 Evaluate

Indoco Remedies has acquired the Clinical/Contract Research Organisation (CRO) division of Piramal Enterprises (PEL). The acquisition will be effective from April 06, 2015 and the company will acquire the assets of the division along with its employees in an all cash-deal and the same would be funded via internal accruals.

Equipped with a 98-bed facility, the CRO (formerly known as Wellquest), is located in Hyderabad and spread across 30,000 square feet. It is equipped with monitoring stations, phlebotomy stations, four-bed ICU, state-of-the-art analytical lab and capabilities of eCTD submission. It also has regulatory approvals from several bodies including USFDA and was the first CRO from India to receive GCP certification from UK-MHRA.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.




Indoco Remedies Share Price

304.90 5.15 (1.72%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1453.25
Dr. Reddys Lab 5792.95
Cipla 1459.85
Zydus Lifesciences 1032.25
Lupin 1583.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.